Single-Cell Secretion Cytokine Signatures – Enhanced Tools For Therapeutic Design and Prediction of Clinical Response
Miles Rackliff,
Senior Sales Manager – Northern Europe,
IsoPlexis
We will present data showing how polyfunctionality measured by IsoPlexis, correlates with patient objective response, can be used to enhance pre-clinical development across CAR-T and combination therapies.
|
|
